MicroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy

Bibliography

• Yi R, Fuchs E. MicroRNAs and their roles in mammalian stem cells. J Cell Sci 2011;124(Pt 11):1775-83
   Google Scholar
• Zhao Z, Moley KH, Gronowski AM. Diagnostic potential for miRNAs as biomarkers for pregnancy-specific diseases. Clin Biochem 2013;46(10-11):953-60
   Google Scholar
• Miao CG, Yang YY, He X, et al. Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. Cell Signal 2013;25(10):2069-78
   PubMed Web of Science ®Google Scholar
• Hu SJ, Ren G, Liu JL, et al. MicroRNA expression and regulation in mouse uterus during embryo implantation. J Biol Chem 2008;283(34):23473-84
   Google Scholar
• Zhao Z, Zhao Q, Warrick J, et al. Circulating microRNA miR-323-3p as a biomarker of ectopic pregnancy. Clin Chem 2012;58(5):896-905
   PubMed Web of Science ®Google Scholar
• Miao CG, Huang C, Huang Y, et al. MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats. Cell Signal 2013;25(3):598-608
   PubMed Web of Science ®Google Scholar
• Miura K, Miura S, Yamasaki K, et al. Identification of pregnancy-associated microRNAs in maternal plasma. Clin Chem 2010;56(11):1767-71
   PubMed Web of Science ®Google Scholar
• Ammari M, Jorgensen C, Apparailly F. Impact of microRNAs on the understanding and treatment of rheumatoid arthritis. Curr Opin Rheumatol 2013;25(2):225-33
   PubMed Web of Science ®Google Scholar
• Xu WD, Liu SS, Pan HF, et al. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: a meta-analysis. Joint Bone Spine 2012;79(6):566-9
   Google Scholar
• Pandis I, Ospelt C, Karagianni N, et al. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis 2012;71(10):1716-23
   PubMed Web of Science ®Google Scholar
• Thomas P, Fenech M. A review of genome mutation and Alzheimer's disease. Mutagenesis 2007;22(1):15-33
   Google Scholar
• Miao C, Liu J, Zhang Y, et al. [Chuju total flavonoids control the SFRP4 expression in Wnt pathway in rheumatoid arthritis model rats]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2013;38(7):715-21
   Google Scholar
• Pauley KM, Chan EK. MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci 2008;1143:226-39
   PubMed Web of Science ®Google Scholar
• Hayes A, Thaker U, Iwatsubo T, et al. Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease. Neurosci Lett 2002;331(3):171-4
   Google Scholar
• Davidovic L, Navratil V, Bonaccorso CM, et al. A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model. Genome Res 2011;21(12):2190-202
   PubMed Web of Science ®Google Scholar
• Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66(4):817-22
   PubMed Web of Science ®Google Scholar
• Delay C, Calon F, Mathews P, et al. Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol Neurodegener 2011;6:70
   Google Scholar
• Westmark CJ, Westmark PR, O'Riordan KJ, et al. Reversal of fragile X phenotypes by manipulation of AbetaPP/Abeta levels in Fmr1KO mice. PLoS ONE 2011;6(10):e26549
   Google Scholar
• Siniscalco D, Sapone A, Giordano C, et al. Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord 2013;43(11):2686-95
   Google Scholar
• Sheinerman KS, Tsivinsky VG, Crawford F, et al. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging (Albany NY) 2012;4(9):590-605
   PubMedGoogle Scholar
• Roberts JE, Bailey DB, Jr, Mankowski J, et al. Mood and anxiety disorders in females with the FMR1 premutation. Am J Med Genet B Neuropsychiatr Genet 2009;150B(1):130-9
   PubMed Web of Science ®Google Scholar
• Yi YH, Sun XS, Qin JM, et al. Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene. J Neurosci Methods 2010;190(1):34-8
   Google Scholar
• Yarchoan M, Louneva N, Xie SX, et al. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. J Neurol Sci 2013;333(1-2):9-12
   Google Scholar
• Winblad B, Jelic V. Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors. Alzheimer Dis Assoc Disord 2004;18(Suppl 1):S2-8
   PubMedGoogle Scholar
• Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256(3):183-94
   PubMed Web of Science ®Google Scholar
• Daponte A, Deligeoroglou E, Pournaras S, et al. Interleukin-15 (IL-15) and anti-C1q antibodies as serum biomarkers for ectopic pregnancy and missed abortion. Clin Dev Immunol 2013;2013:637513
   PubMedGoogle Scholar
• Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, et al. Pregnancy-associated miRNA-clusters. J Reprod Immunol 2013;97(1):51-61
   PubMed Web of Science ®Google Scholar
• Zhi F, Cao X, Xie X, et al. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS ONE 2013;8(2):e56718
   PubMed Web of Science ®Google Scholar
• Fu G, Brkic J, Hayder H, et al. MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci 2013;14(3):5519-44
   PubMed Web of Science ®Google Scholar
• Chambers CD, Johnson D, Xu R, et al. Risks and safety of pandemic h1n1 influenza vaccine in pregnancy: birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine 2013;1(44):5026-32
   Google Scholar
• Higashijima A, Miura K, Mishima H, et al. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy. Prenat Diagn 2013;33(3):214-22
   PubMed Web of Science ®Google Scholar
• Xiong L, Wang F, Huang X, et al. DNA demethylation regulates the expression of miR-210 in neural progenitor cells subjected to hypoxia. FEBS J 2012;279(23):4318-26
   PubMed Web of Science ®Google Scholar